1. Sham, JS, Wei, WI, Zong, YS, et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet 1990; 335: 371–374.
Google Scholar | Crossref | Medline | ISI2. Chang, CM, Yu, KJ, Mbulaiteye, SM, et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 2009; 143: 209–221.
Google Scholar | Crossref | Medline | ISI3. Cao, SM, Simons, MJ, Qian, CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 2011; 30: 114–119.
Google Scholar | Crossref | Medline4. Mahdavifar, N, Ghoncheh, M, Mohammadian-Hafshejani, A, et al. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res Perspect 2016; 7: 360–372.
Google Scholar | Crossref | Medline5. Lao, TD, Nguyen, TV, Nguyen, DH, et al. miR-141 is up-regulated in biopsies from Vietnamese patients with nasopharyngeal carcinoma. Braz Oral Res 2018; 32: e126.
Google Scholar | Crossref | Medline6. Lao, TD, Nguyen, DH, Le, THA. Study of mir-141 and its potential targeted mRNA PTEN expression in nasopharyngeal carcinoma: from in silico to initial experiment analysis. AJPRHC 2018; 10: 66–74.
Google Scholar | Crossref7. Lao, TD, Le, THA. Epidemiology, incidence and mortality of nasopharynx cancer in Southeast Asia: an update report. Adv Life Sci 2020; 7: 86–90.
Google Scholar8. Tabuchi, K, Nakayama, M, Nishimura, B, et al. Early detection of nasopharyngeal carcinoma. Int J Otolaryngol 2011; 2011: 638058–6.
Google Scholar | Crossref | Medline9. Li, M, Wang, C, Yu, B, et al. Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis. Biosci Rep 2019; 39: BSR20190923.
Google Scholar | Crossref | Medline10. Tao, Q, Chan, AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007; 9: 1–24.
Google Scholar | Crossref | Medline11. Tsao, SW, Yip, YL, Tsang, CM, et al. Etiological factors of nasopharyngeal carcinoma. Oral Oncol 2014; 50: 330–338.
Google Scholar | Crossref | Medline | ISI12. Wu, K, Xu, XN, Chen, Y, et al. RASSF1A Gene methylation is associated with nasopharyngeal carcinoma risk in Chinese. Asian Pac J Cancer Prev 2015; 16: 2283–2287.
Google Scholar | Crossref | Medline13. Wang, LH, Wu, CF, Rajasekaran, N, et al. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem 2018; 51: 2647–2693.
Google Scholar | Crossref | Medline14. Locke, WJ, Guanzon, D, Ma, C, et al. DNA Methylation cancer biomarkers: translation to the clinic. Front Genet 2019; 10: 1150.
Google Scholar | Crossref | Medline15. Chan, SL, Chu, S, Mak, C, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med 2017; 377: 513–522.
Google Scholar | Crossref | Medline16. Zinatizadeh, MR, Momeni, SA, Zarandi, PK, et al. The role and function of Ras-association domain family in cancer: a review. Genes Dis 2019; 6: 378–384.
Google Scholar | Crossref | Medline17. García-Gutiérrez, L, McKenna, S, Kolch, W, et al. RASSF1A Tumour suppressor: target the network for effective cancer therapy. Cancers (Basel) 2020; 12: 29.
Google Scholar | Crossref18. Malpeli, G, Innamorati, G, Decimo, I, et al. Methylation dynamics of RASSF1A and Its impact on cancer. Cancers (Basel) 2019; 11: 59.
Google Scholar | Crossref19. Donninger, H, Vos, MD, Clark, GJ. The RASSF1A tumor suppressor. J Cell Sci 2007; 120: 3163–3172,
Google Scholar | Crossref | Medline | ISI20. Donninger, H, Clark, J, Rinaldo, F, et al. The RASSF1A tumor suppressor regulates XPA-mediated DNA repair. Mol Cell Biol 2015; 35: 277–287.
Google Scholar | Crossref | Medline21. Challouf, S, Ziadi, S, Zaghdoudi, R, et al. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients. Clin Chim Acta 2012; 413: 795–802.
Google Scholar | Crossref | Medline22. Tian, F, Yip, SP, Kwong, DLW, et al. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Cancer Epidemiol 2013; 37: 708–713.
Google Scholar | Crossref | Medline23. Moher, D, Liberati, A, Tetzlaff, J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
Google Scholar | Crossref | Medline | ISI24. Higgins, JP, Thompson, SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
Google Scholar | Crossref | Medline | ISI25. DerSimonian, R . Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996; 15: 1237–1248.
Google Scholar | Crossref | Medline | ISI26. Higgins, JP, Thompson, SG, Deeks, JJ, et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557–560.
Google Scholar | Crossref | Medline27. Begg, CB, Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–1101.
Google Scholar | Crossref | Medline | ISI28. Egger, M, Davey, SG, Schneider, M, et al. Bias in meta-analysis detected by a simple, graphical test Br Med J 1997; 315: 629–634.
Google Scholar | Crossref | Medline29. Chow, LS, Lo, KW, Kwong, J, et al. RASSF1A Is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 2004; 109: 839–847.
Google Scholar | Crossref | Medline30. Chang, HS, Chan, A, Kwong, DLW, et al. Evaluation Of hypermethylated tumor suppressor genes As tumor markers In mouth And throat rinsing fluid, nasopharyngeal swab And peripheral blood Of nasopharygeal carcinoma patient. Int J Cancer 2003; 105: 851–855.
Google Scholar | Crossref | Medline31. Kwong, J, Lo, KW, To, KF, et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 2002; 8: 131–837.
Google Scholar | Medline32. Wong, TS, Kwong, DLW, Sham, JST, et al. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res 2004; 10: 2401–2406.
Google Scholar | Crossref | Medline | ISI33. Zhou, L, Jiang, W, Ren, C, et al. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia 2005; 7: 809–815.
Google Scholar | Crossref | Medline34. Wang, T, Liu, H, Chen, Y, et al. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma. J Exp Clin Cancer Res 2009; 28: 160.
Google Scholar | Crossref | Medline35. Hutajulu, SH, Indrasari, SR, Indrawati, LP, et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer 2011; 10: 48.
Google Scholar | Crossref | Medline36. Fendri, A, Masmoudi, A, Khabir, A, et al. Inactivation of RASSF1A, RARβ2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Cancer Biol Ther 2009; 8: 444–451.
Google Scholar | Crossref | Medline | ISI37. Tong, JHM, Tsang, RKY, Lo, KW, et al. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 2002; 8: 2612–2619.
Google Scholar | Medline | ISI38. Zhang, Z, Sun, D, Hutajulu, SH, et al. Development of a Non-invasive method, Multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma. PLoS ONE 2012; 7: e45908.
Google Scholar | Crossref | Medline39. Wong, TS, Tang, KC, Kwong, DLW, et al. Differential gene methylation in undifferentiated nasopharyngeal carcinoma. Int J Onco 2003; 22: 869–874.
Google Scholar | Medline40. Qiu, GH, Tan, LKS, Loh, KS, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 2004; 23: 4793–4806.
Google Scholar | Crossref | Medline41. Lo, KW, Kwong, J, Hui, ABY, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001; 61: 3877–3881.
Google Scholar | Medline42. Yang, X, Dai, W, Kwong, DLW, et al. Epigenetic markers for Non-invasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int J Cancer 2015; 136: 1–29.
Google Scholar | Crossref | Medline43. Thieu, HH, Lao, DT, Le, HAT. Characterization of promoter hypermethylation of tumor suppressor gene RASSF1A and its association with the risk of nasopharyngeal carcinoma. Pharmacophore 2020; 11: 56–62.
Google Scholar44. Rountree, MR, Bachman, KE, Herman, JG, et al. DNA Methylation, chromatin inheritance, and cancer. Oncogene 2001; 20: 3156–3165.
Google Scholar | Crossref | Medline | ISI45. Xiong, W, Zeng, ZY, Xia, JH. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004; 64: 1972–1974.
Google Scholar | Crossref | Medline46. Hui, AB, Lo, KW, Leung, SF, et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer 1999; 82: 498–503.
Google Scholar | Crossref | Medline47. Zhang, J, Shen, Z, Liu, H, et al. Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma. Cancer Manag Res 2018; 10: 2953–2964.
Google Scholar | Crossref | Medline48. Huang, Z, Bassil, CF, Murphy, SK. Methylation-specific PCR. Methods Mol Biol 2013; 1049: 75–82.
Google Scholar | Crossref | Medline49. Agodi, A, Barchitta, M, Quattrocchi, A, et al. DAPK1 Promoter methylation and cervical cancer risk: a systematic review and a meta-analysis. PLoS One 2015; 10: e0135078.
Google Scholar | Crossref | Medline50. Hussmann, D, Hansen, LL. Methylation-sensitive high resolution melting (MS-HRM). In: Tost, J (ed) DNA methylation protocols. Methods in molecular biology. New York, NY: Humana Press, 2018, pp.1708.
Google Scholar | Crossref